Team
Insightful. Experienced. Entrepreneurial.
PIC Therapeutics' team of passionate leaders, board members and advisors brings well over 100 years of combined biopharmaceutical experience in research and development, launching innovative companies and cultivating their growth, and delivering breakthrough medicines to patients. We have also assembled a network of strategic partnerships with leading consultants and contractors, allowing us to benefit from their scale to efficiently and expeditiously advance our program.
Dr. Kathy Bowdish, President & CEO
Gerry Brunk, MBA, Co-founder and Managing Director at Lumira Ventures
Belinda Termeer, Termeer Family Office, Harvard Medical School Board of Fellows
Gerhard Wagner, PhD, Scientific Co-Founder, Elkan Blout Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Alan E. Walts, PhD, Executive Chair, Advent Life Sciences
Tal Zaks, M.D., Ph.D., Partner at Orbimed
Keith Flaherty, MD, Director of Clinical Research at the Cancer Center and Richard Saltonstall Endowed Chair in Oncology at Massachusetts General Hospital, and Professor of Medicine at Harvard Medical School
Dejan Juric, MD, Director of the Termeer Center for Targeted Therapies & Program Director of the Investigational Cancer Therapeutics Program at Mass General Hospital Cancer Center
Jennifer Petter, PhD, Founder and CSO, Arrakis
Nahum Sonenberg, PhD, Rosalind and Morris Goodman Cancer Centre, McGill
Yat Sun Or, PhD, CSO, Enanta Pharmaceuticals
Jan van Heek, MBA, Board Member, Amarin Corp, Minerva Neurosciences
Gerhard Wagner, PhD, Scientific Co-Founder, Elkan Blout Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School